Goldman Sachs Invests in Aragen Life Sciences
Goldman Sachs Invests in Aragen Life Sciences Wednesday, May 19, 2021 11:55AM IST (6:25AM GMT) Hyderabad, India: Aragen Life Sciences (“Aragen”), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced today that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and manufacturing services ...
Source: businesswireindia.com